In addition, we found that the Dox + PTPRZ1 group showed more obvious activation of the NF-κB pathway than PTPRZ1 group, thus demonstrating that PTPRZ1 plays an essential role in promoting the activation of the NF-κB pathway in breast cancer cells undergoing chemotherapy. This evidence concerns the gene PTPRZ1 and breast carcinoma.